Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1-2/2003

01-03-2003

Calcitonin inhibits prolactin promoter activity in rat pituitary GGH3 cells

Evidence for involvement of p42/44 mitogen-activated protein kinase in calcitonin action

Authors: Yuan Ren, Ya-Ping Sun, Girish V. Shah

Published in: Endocrine | Issue 1-2/2003

Login to get access
Metadata
Title
Calcitonin inhibits prolactin promoter activity in rat pituitary GGH3 cells
Evidence for involvement of p42/44 mitogen-activated protein kinase in calcitonin action
Authors
Yuan Ren
Ya-Ping Sun
Girish V. Shah
Publication date
01-03-2003
Publisher
Humana Press
Published in
Endocrine / Issue 1-2/2003
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:20:1-2:13

Other articles of this Issue 1-2/2003

Endocrine 1-2/2003 Go to the issue

OriginalPaper

Changes in estrogen receptor-α expression in hypothalamic dopaminergic neurons during proestrous prolactin surge

OriginalPaper

Effects of prolactin on cloned human t-lymphocytes

EditorialNotes

Introduction to special issue

OriginalPaper

Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism

OriginalPaper

Dependence of prolactin release on coupling between Ca2+ mobilization and voltage-gated Ca2+ influx pathways in rat lactotrophs

OriginalPaper

Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits